Graves disease and provide information useful in determining therapeutic treatment [1] . The primary use for the measurement of serum Tg concentrations is management of patients with differentiated thyroid carcinoma treated by total ablation of the thyroid [2, 3] .After thyroidectomy and 1311 ablation therapy, serum Tg concentrations should decline to normal or undetectable. Any increase in serum Tg is suggestive of residual or recurrent disease or of metastasis. Numerous methods have been developed to measure Tg in serum, including RIAs [4, 5] ,IRMAs [6, 7] , and enzyme immunoassays [8] [9] [10] . A major difficulty associated with all these assays is the influence of Tg autoantibodies on the assays. Autoantibodies have been shown to cause either underor overestimation of Tg concentrations in RIAs [4] . The development of IRMAs and enzyme immunoassays has reduced and limited the autoantibody interference to falsely reporting lowered values [6, 10, 11] .
In an effort to provide more reliable information concerning Tg concentrations in all specimens, regardless of the absence or presence of autoantibodies, we have developed an ELISA for measuring Tg, in which a recovery procedure is included to assist in the interpretation of results. This ELISA is a solidphase "sandwich"-type assay, using polyclonal antibody to Tg as the capture antibody and two monoclonal antibodies as the second antibodies.
We used a sensitive commercially available RIA to measure Tg autoantibodies and evaluated the effects of these autoantibodies on our assay.
Materials and Methods

MATERIALS
Reagents. Bovine gamma globulin and Tween 20 were purchased Tg ELISA. Controls and samples were diluted threefold in antigen diluent before assay. Before use, the coated wells were washed four times with 400 pL/well of wash solution, soaking for 60-65 s for each wash. All subsequent washes were performed the same way. Duplicate 100-ML aliquots of the calibrators, diluted controls, and diluted samples were added to the coated wells and then incubated at room temperature for 2 h in the dark on a horizontal rotator at 80 rpm. After another wash step, 100 .tL of two monoclonal antibodies to human Tg (clone 24Tg/5E6
and clone 24Tg/5F9; Biodesign International) diluted in conjugate diluent was added to each well. The samples were again incubated at room temperature for 2 h in the dark on a rotator at 80 rpm, after which the wells were washed again and 100 j.tL of peroxidase-conjugated goat anti-mouse immuno- Fig. 1 . For data reduction we used a best-fit linear curve. The limit of detection was established by determining the precision of the assay through the use of a calibration curve in which n = 10 for the 0 and 1 j.tg/L calibrators. Other calibrators were run in duplicate, and a best-fit linear curve was used for data reduction.
The limit of detection of this assay, based on 99% confidence, is 1 j.tg/L. Dilution studies also supported a limit of detection of 1 j.tg/L. Five samples containing autoantibodies to Tg (Table 1) and five samples with undetectable amounts of Tg autoantibodies (Table 2) were evaluated. The % observed/expected consistently decreased when the value of the diluted sample was less than the 1 Mg/L limit of detection; therefore, dilutions resulting in <I ag/L were not included in this study. The % observed/ Thyroglobulln conc, ag/L Mean (SD) = 103% (11.8%). (Fig. 4 ).
Discussion
The current RIA methods used for measuring Tg in serum are subject to problems of interference by Tg autoantibodies [4] . In our laboratory, when an RIA method was used, we routinely screened for Tg autoantibodies on all samples submitted for Tg measurement and did not report Tg results for any samples that were positive for autoantibodies.
To provide more complete and useful information to clinicians, we developed an ELISA for measuring Tg in serum that also includes the determination of percent recovery as an aid for assessing the degree of autoantibody interference.
The influence of autoantibodies on the ELISA was evaluated
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Thyroglobulin Autoaritibodies (kufL) by determining the percent recovery in the actual samples being tested for Tg. The immune response is polyclonal, and individual samples have been shown to have populations of autoantibodies with unique specificity and affinity for Tg [12] . In addition, the thyroglobulin molecule has been shown to exhibit heterogeneity of iodine content in different clinical states [13] , here, we also evaluated other solutions at 100 and 200 g/L.
Recoveries were generally better at the high concentrations of supplementation.
We felt the lower value of 50 .tg/L would be more sensitive to autoantibody interference and thus be a better indictor. Use of this lower supplementation concentration is also less likely to raise the Tg value of the sample to greater than the highest-concentration calibrator, thus keeping to a minimum the number of samples needing to be diluted and retested.
Other studies evaluating the influence of autoantibodies on Tg assays often used only one preparation of autoantibody to add to the Tg samples [7, 8] .This approach measures only the influence of that one particular autoantibody population on the assay and does not account for the effects of the autoantibodies in each individual clinical sample. Given the heterogeneity of autoantibodies, it is unlikely that any Tg assay could be developed in which autoantibodies have no effect at all. By acknowledging that the assay can be influenced by autoantibodies and including a method for evaluating the degree of interference, the laboratorian can provide more useful clinical information to the physician.
The assay presented here was designed to minimize the autoantibody influence by using a sandwich method with polyclonal and monoclonal antibodies to better ensure that a number of epitopes on the Tg molecule will be recognized.
To provide additional information when autoantibodies in a given sample are of the specificity and affinity to interfere with the assay, we also determined the percent recovery and autoantibody concentration.
For the cutoff level we chose 80% recovery of added Tg because all the samples tested that had no measurable autoantibodies gave a recovery value of >80%. The inability of this assay to detect >80% of added Tg in some samples containing Tg autoantibodies (Fig. 3, bottom) indicates that some interference from Tg autoantibodies is present and that this interference causes falsely lower Tg values to be reported in these samples. These data support other studies with sandwich-type methods, which also showed lowered Tg values in autoantibodycontaining samples [6, 11] .The differences in slope between the ELISA and the two RIA methods also suggest that autoantibody interference causes lower values in the RIA than in the ELISA. Because of the possibility of interference in an ELISA method, our reports on Tg concentrations include measurement of Tg autoantibodies by a sensitive RIA and determination of the percent recovery of added Tg. RIAs for measuring Tg autoantibodies have greater sensitivity than the commonly used tanned erythrocyte tests [4, 14, 15] . As indicated in Fig. 3  (bottom) , recovery values may be acceptable in some samples containing substantial amounts of autoantibodies.
In summary, the ELISA developed in our laboratory with a combination of polyclonal and monoclonal Tg antibodies is a sensitive assay with good precision and reproducibility.
By including measurements of Tg autoantibody and recovery of added Tg for each sample tested, additional information is provided to the clinician that can be helpful in better interpreting the Tg results.
